wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36250585-5C8451A3-E673-4B46-AA63-08D04C51AECE
Q36250585-5C8451A3-E673-4B46-AA63-08D04C51AECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36250585-5C8451A3-E673-4B46-AA63-08D04C51AECE
Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence
P2860
Q36250585-5C8451A3-E673-4B46-AA63-08D04C51AECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36250585-5C8451A3-E673-4B46-AA63-08D04C51AECE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f0aa32050559fa3ad3c77b1948396624e93a6446
P2860
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.